Clinical Trial Update: Tka Assay for CDK4/6i [NA]

View source ↗

Summary

Update on a clinical trial evaluating the Tka Assay for CDK4/6 inhibitors in metastatic breast cancer, including HER2-negative disease. The trial status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Yale University | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma | NA | Status: COMPLETED